Title:
PANCREATIC CANCER DIAGNOSIS ASSIST METHOD AND PHARMACEUTICAL COMPOSITION FOR PANCREATIC CANCER TREATMENT
Document Type and Number:
Japanese Patent JP2021139895
Kind Code:
A
Abstract:
To provide a method for diagnosing pancreatic cancer early, and a pharmaceutical composition capable of treating pancreatic cancer.SOLUTION: A pancreatic cancer diagnosis assist method comprises (1) a step of contacting a sample derived from a subject suspected of having pancreatic cancer with an antibody specific for ganglioside GM2 and/or an antibody specific for ganglioside GD1a, to obtain an antigen-antibody complex, and (2) a step of detecting the antigen-antibody complex. A pharmaceutical composition for the treatment of pancreatic cancer contains a GM2 immune complex in which an anticancer drug or a photosensitizer is bound to the antibody specific for ganglioside GM2, and/or a GD1a immune complex in which an anticancer drug or photosensitizer is bound to the antibody specific for ganglioside GD1a.SELECTED DRAWING: None
Inventors:
ISHIWATA TOSHIYUKI
SASAKI NORIHIKO
SASAKI NORIHIKO
Application Number:
JP2021030182A
Publication Date:
September 16, 2021
Filing Date:
February 26, 2021
Export Citation:
Assignee:
TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INST OF GERONTOLOGY
International Classes:
G01N33/574; A61K31/409; A61K41/00; A61K45/00; A61K47/68; A61P35/00
Attorney, Agent or Firm:
Kenjiro Yamaguchi
Kenichi Morita
Kenichi Morita